Royal Bank Of Canada Acadia Pharmaceuticals Inc Transaction History

Royal Bank Of Canada

$479 Billion
Q4 2024

A detailed history of Royal Bank Of Canada transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 46,176 shares of ACAD stock, worth $686,175. This represents 0.0% of its overall portfolio holdings.

Number of Shares

46,176

Previous 54,076 14.61%

Holding current value

$686,175

Previous $832,000 1.8%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$14.29 - $18.76 $112,891 - $148,204	-7,900 Reduced 14.61%	46,176 $847,000
Q3 2024 Nov 14, 2024	BUY	$15.14 - $19.14 $66,449 - $84,005	4,389 Added 8.83%	54,076 $832,000
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $123,729 - $155,888	8,463 Added 20.53%	49,687 $807,000
Q1 2024 Nov 05, 2024	SELL	$17.79 - $30.86 $150,556 - $261,168	-8,463 Reduced 17.03%	41,224 $762,000
Q1 2024 May 15, 2024	SELL	$17.79 - $30.86 $469,940 - $815,197	-26,416 Reduced 39.05%	41,224 $762,000
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $225,296 - $344,450	10,842 Added 19.09%	67,640 $2.12 Million
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $89,111 - $143,117	4,276 Added 8.14%	56,798 $1.18 Million
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $52,616 - $75,821	2,956 Added 5.96%	52,522 $1.26 Million
Q1 2023 May 15, 2023	SELL	$16.32 - $20.92 $362,875 - $465,156	-22,235 Reduced 30.97%	49,566 $932,000
Q4 2022 Feb 14, 2023	BUY	$14.2 - $18.63 $21,427 - $28,112	1,509 Added 2.15%	71,801 $1.14 Million
Q3 2022 Nov 14, 2022	SELL	$14.11 - $18.27 $121,416 - $157,213	-8,605 Reduced 10.91%	70,292 $1.15 Million
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $16,418 - $34,351	1,262 Added 1.63%	78,897 $1.11 Million
Q1 2022 May 16, 2022	SELL	$20.94 - $27.5 $364,523 - $478,720	-17,408 Reduced 18.32%	77,635 $1.88 Million
Q4 2021 Feb 14, 2022	BUY	$16.79 - $27.09 $205,257 - $331,175	12,225 Added 14.76%	95,043 $2.22 Million
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $3,487 - $5,474	221 Added 0.27%	82,818 $1.38 Million
Q2 2021 Aug 16, 2021	BUY	$19.4 - $27.42 $1.6 Million - $2.26 Million	82,597 New	82,597 $2.02 Million

Others Institutions Holding ACAD

# of Institutions

322

Shares Held

165M

Call Options Held

855K

Put Options Held

350K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.4B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Acadia Pharmaceuticals Inc Transaction History